Xia Bu

9.7k citations

27 papers · 5.6k indexed · 2 hit papers · h-index 17

Impact in

Oncology top 1%
- Cancer Immunotherapy and Biomarkers
Cancer Research top 1%
- Cancer-related molecular mechanisms research

Papers in ⓘ

Immunology 14
- Immune Cell Function and Interaction 7
- Immunotherapy and Immune Responses 5
- Galectins and Cancer Biology 3
- Immune cells in cancer 3
- Phagocytosis and Immune Regulation 2
Oncology 11
- Cancer Immunotherapy and Biomarkers 9
- CAR-T cell therapy research 2

Co-authors: Gordon J. Freeman (14 shared papers)Jun Liu (1 shared paper)Deng Pan (1 shared paper)Avinash Sahu (1 shared paper)Jingxin Fu (1 shared paper)X. Shirley Liu (1 shared paper)Kai W. Wucherpfennig (1 shared paper)Nicole Traugh (1 shared paper)
Journals: Advances in experimental medicine and biology (2 papers)Blood (2 papers)The Journal of Immunology (2 papers)Proceedings of the National Academy of Sciences (1 paper)Nature Medicine (1 paper)
Partner nations: United States China Japan

In The Last Decade

Xia Bu

25 papers receiving 5.6k citations

Hit Papers

align trajectories log scale

Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response 2018 · 3.2k citations

Peers

Countries citing papers authored by Xia Bu

Since Specialization

Citations

This map shows the geographic impact of Xia Bu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xia Bu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xia Bu more than expected).

Fields of papers citing papers by Xia Bu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xia Bu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xia Bu. The network helps show where Xia Bu may publish in the future.

Co-authors

The 25 scholars most cited alongside Xia Bu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Xia Bu Line = papers co-authored together Xia Bu links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response Nature Medicine ·Peng Jiang, Shengqing Gu, Deng Pan, Jingxin Fu, Avinash Sahu, Xihao Hu, Ziyi Li, Nicole Traugh, Xia Bu, Bo Li, Jun Liu, Gordon J. Freeman, Myles Brown, Kai W. Wucherpfennig, X. Shirley Liu Hit paper breakdown →	2018	3242
2	Cyclin D–CDK4 kinase destabilizes PD-L1 via cullin 3–SPOP to control cancer immune surveillance Nature ·Jinfang Zhang, Xia Bu, Haizhen Wang, Yasheng Zhu, Yan Geng, Naoe Taira Nihira, Yuyong Tan, Yanpeng Ci, Fei Wu, Xiangpeng Dai, Jianping Guo, Yuhan Huang, Caoqi Fan, Shancheng Ren, Yinghao Sun, Gordon J. Freeman, Piotr Siciński, Wenyi Wei Hit paper breakdown →	2017	736
3	TIM-family Proteins Promote Infection of Multiple Enveloped Viruses through Virion-associated Phosphatidylserine PLoS Pathogens ·Stephanie Jemielity, Jinyize J. Wang, Ying Chan, Asim A. Ahmed, Wenhui Li, Sheena Monahan, Xia Bu, Michael Farzan, Gordon J. Freeman, Dale T. Umetsu, Rosemarie H. DeKruyff, Hyeryun Choe	2013	272
4	T Cell/Transmembrane, Ig, and Mucin-3 Allelic Variants Differentially Recognize Phosphatidylserine and Mediate Phagocytosis of Apoptotic Cells The Journal of Immunology ·Rosemarie H. DeKruyff, Xia Bu, Ángela Ballesteros, César Santiago, Yee-Ling Chim, Hyun‐Hee Lee, Piia Karisola, Muriel Pichavant, Gerardo Kaplan, Dale T. Umetsu, Gordon J. Freeman, José M. Casasnovas	2010	265
5	RGMb is a novel binding partner for PD-L2 and its engagement with PD-L2 promotes respiratory tolerance The Journal of Experimental Medicine ·Yanping Xiao, Sanhong Yu, Baogong Zhu, Denis Bedoret, Xia Bu, Loise M. Francisco, Ping Hua, Jonathan S. Duke‐Cohan, Dale T. Umetsu, Arlene H. Sharpe, Rosemarie H. DeKruyff, Gordon J. Freeman	2014	256
6	Energy status dictates PD-L1 protein abundance and anti-tumor immunity to enable checkpoint blockade Molecular Cell ·Xiaoming Dai, Xia Bu, Yang Gao, Jianping Guo, Jia Hu, Cong Jiang, Zhao Zhang, Kexin Xu, Jinzhi Duan, Shaohui He, Jinfang Zhang, Lixin Wan, Tianjie Liu, Xiaobo Zhou, Mien‐Chie Hung, Gordon J. Freeman, Wenyi Wei	2021	160
7	The Hematopoiesis-Specific GTP-Binding Protein RhoH Is GTPase Deficient and Modulates Activities of Other Rho GTPases by an Inhibitory Function Molecular and Cellular Biology ·Xiaoyu Li, Xia Bu, Binfeng Lu, Hava Avraham, Richard A. Flavell, Bing Lim	2002	116
8	A secreted PD-L1 splice variant that covalently dimerizes and mediates immunosuppression Cancer Immunology Immunotherapy ·Kathleen M. Mahoney, Sachet A. Shukla, Nikolaos Patsoukis, Apoorvi Chaudhri, Edward P. Browne, Arnon Arazi, Thomas Eisenhaure, William F. Pendergraft, Ping Hua, Hung C. Pham, Xia Bu, Baogong Zhu, Nir Hacohen, Edward F. Fritsch, Vassiliki A. Boussiotis, Catherine J. Wu, Gordon J. Freeman	2018	112
9	Immuno-PET identifies the myeloid compartment as a key contributor to the outcome of the antitumor response under PD-1 blockade Proceedings of the National Academy of Sciences ·Mohammad Rashidian, Martin W. LaFleur, Vincent L. Verschoor, Anushka Dongre, Yun Zhang, Thao H. Nguyen, Stephen C. Kolifrath, Amir Reza Aref, Christie J. Lau, Cloud P. Paweletz, Xia Bu, Gordon J. Freeman, M. Inmaculada Barrasa, Robert A. Weinberg, Arlene H. Sharpe, Hidde L. Ploegh	2019	87
10	Cdc42 and RhoB Activation Are Required for Mannose Receptor-mediated Phagocytosis by Human Alveolar Macrophages Molecular Biology of the Cell ·Jianmin Zhang, Jinping Zhu, Xia Bu, Melanie T. Cushion, T. Bernard Kinane, Hava Avraham, Henry Koziel	2004	70
11	Apoptotic Cells Activate NKT Cells through T Cell Ig-Like Mucin-Like–1 Resulting in Airway Hyperreactivity The Journal of Immunology ·Hyun-Hee Lee, Everett Meyer, Sho Goya, Muriel Pichavant, Hye Young Kim, Xia Bu, Sarah E. Umetsu, Jennifer Jones, Paul B. Savage, Yoichiro Iwakura, José M. Casasnovas, Gerardo Kaplan, Gordon J. Freeman, Rosemarie H. DeKruyff, Dale T. Umetsu	2010	63
12	PRMT1 mediated methylation of cGAS suppresses anti-tumor immunity Nature Communications ·Jing Liu, Xia Bu, Chen Chu, Xiaoming Dai, John M. Asara, Piotr Siciński, Gordon J. Freeman, Wenyi Wei	2023	50
13	Process elongation of oligodendrocytes is promoted by the Kelch‐related actin‐binding protein Mayven Journal of Neurochemistry ·Shuxian Jiang, Hava Avraham, Shin‐Young Park, Tae‐Aug Kim, Xia Bu, Seyha Seng, Shalom Avraham	2005	31
14	Immune Checkpoint Blockade in Breast Cancer Therapy Advances in experimental medicine and biology ·Xia Bu, Yihui Yao, Xiaoyü Li	2017	27
15	Cell-type-specific regulation of raft-associated Akt signaling Cell Death and Disease ·Y Liu, Guang Yang, Xia Bu, Guangkuo Liu, Jeffrey Ding, Peichao Li, William Jia	2011	19
16	Genomic landscape of young ATLL patients identifies frequent targetable CD28 fusions Blood ·Noriaki Yoshida, Kay Shigemori, Nicholas L. Donaldson, Christopher Trevisani, Nicolas A. Cordero, Kristen E. Stevenson, Xia Bu, Fumiko Arakawa, Mai Takeuchi, Koichi Ohshima, Akinori Yoda, Samuel Y. Ng, David M. Weinstock	2020	18
17	Mayven induces c-Jun expression and cyclin D1 activation in breast cancer cells Oncogene ·Xia Bu, Hava Avraham, Xiaoyu Li, Bing Lim, Shuxian Jiang, Yigong Fu, Richard G. Pestell, Shalom Avraham	2005	17
18	The CX3CL1-CX3CR1 chemokine axis can contribute to tumor immune evasion and blockade with a novel CX3CR1 monoclonal antibody enhances response to anti-PD-1 immunotherapy Frontiers in Immunology ·Apoorvi Chaudhri, Xia Bu, Yunfei Wang, Michael R. Gomez, James A. Torchia, Ping Hua, Shao-Hsi Hung, Michael A. Davies, Gregory Lizée, Ulrich H. von Andrian, Patrick Hwu, Gordon J. Freeman	2023	16
19	Progress in Vaccine Therapies for Breast Cancer Advances in experimental medicine and biology ·Xiaoyü Li, Xia Bu	2017	14
20	Monitoring PD-1 Phosphorylation to Evaluate PD-1 Signaling during Antitumor Immune Responses Cancer Immunology Research ·Xia Bu, Vikram R. Juneja, Carol Reynolds, Kathleen M. Mahoney, Melissa T. Bu, Kathleen A. McGuire, Seth Maleri, Ping Hua, Baogong Zhu, Sarah R. Klein, Edward Greenfield, Philippe Armand, Jerome Ritz, Arlene H. Sharpe, Gordon J. Freeman	2021	11

About Xia Bu

Xia Bu is a scholar working on Immunology, Oncology, Developmental Neuroscience, Cancer Research and Cell Biology, having authored 27 papers that have together received 5.6k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (9 papers), Immune Cell Function and Interaction (7 papers), Immunotherapy and Immune Responses (5 papers), Galectins and Cancer Biology (3 papers), Immune cells in cancer (3 papers), Phagocytosis and Immune Regulation (2 papers), CAR-T cell therapy research (2 papers) and Ginseng Biological Effects and Applications (2 papers). The work is most often cited by research in Oncology (2.6k citations), Cancer Research (1.4k citations), Immunology (1.9k citations), Pulmonary and Respiratory Medicine (2.2k citations) and Molecular Biology (2.3k citations). Xia Bu has collaborated with scholars based in United States, China and Japan. Frequent co-authors include Gordon J. Freeman, Jun Liu, Deng Pan, Avinash Sahu, Jingxin Fu, X. Shirley Liu, Kai W. Wucherpfennig, Nicole Traugh, Shengqing Gu and Peng Jiang. Their work appears in journals such as Advances in experimental medicine and biology, Blood, The Journal of Immunology, Proceedings of the National Academy of Sciences and Nature Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact